Dr. John V. Golding III, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Meharry Medical College School of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 506
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Meharry Medical College School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TN license 38482 -
Cardiovascular Disease Physician
ND license 22266 · TN license 38482
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Erlanger Medical Center Chattanooga, TN
- Essentia Health Fargo, ND
- Union Hospital Inc Terre Haute, IN
- Parkridge Medical Center Chattanooga, TN
Medical groups
- Innovis Health LLC (559 clinicians)
- Union Associated Physicians Clinic, LLC (230 clinicians)
- Centennial Heart LLC (115 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 506
- Services billed
- 1,122
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 301 | 208 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 161 | 157 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 47 | 45 |
| Established patient office or other outpatient visit, 20-29 minutes | 45 | 40 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 33 | 22 |
| New patient office or other outpatient visit, 45-59 minutes | 29 | 29 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 28 | 28 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 24 | 24 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | 19 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carvedilol Other prescribers in Chattanooga, TN | 193 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Chattanooga, TN | 175 |
| Eliquis (apixaban) Other prescribers in Chattanooga, TN | 129 |
| Amlodipine Besylate Other prescribers in Chattanooga, TN | 116 |
| Furosemide Other prescribers in Chattanooga, TN | 102 |
| Metoprolol Succinate Other prescribers in Chattanooga, TN | 101 |
| Entresto (sacubitril/valsartan) Other prescribers in Chattanooga, TN | 99 |
| Metoprolol Tartrate Other prescribers in Chattanooga, TN | 94 |
| Losartan Potassium Other prescribers in Chattanooga, TN | 90 |
| Atorvastatin Calcium Other prescribers in Chattanooga, TN | 79 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 28 payments worth $1,161 in total to this clinician.
| Shockwave Medical, Inc | $392 |
|---|---|
| Penumbra, Inc. | $272 |
| Abbott Laboratories | $189 |
| Abiomed | $148 |
| Novo Nordisk Inc | $49.69 |
| Pfizer Inc. | $40.34 |
| Medtronic, Inc. | $38.18 |
| E.r. Squibb & Sons, L.l.c. | $32.52 |
| Food and Beverage | $1,129 |
|---|---|
| Education | $32.27 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Jan 15, 2025 | Education Ozempic · Diabetes · in-kind | $32.27 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $17,160 in research payments for these studies, mostly to the institutions running them.
- EXPAND II
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.